News brief
On 2026-07-08, according to Xiniu Data, MindRank completed Series B financing, raising USD 52 million. The company is a provider of AI driven innovative drugs research and development services.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年7月8日，据烯牛数据报道，德睿智药完成B轮融资，金额5200万美元。该公司为AI驱动创新药物研发服务商。